Ferritin: Iron Stores, Inflammation, and Why Optimal Differs by Sex

Why the 'Normal' Ferritin Range Is Almost Useless on Its Own

Ferritin is the primary iron-storage protein in the human body. Every cell that needs iron—red blood cell precursors, thyroid peroxidase enzymes, mitochondria—draws on the ferritin pool before circulating iron becomes depleted. Because of this, ferritin is often called the "canary in the coal mine" for iron status: it falls first, before hemoglobin, hematocrit, or transferrin saturation show any problem.

The trouble is that conventional laboratory reference ranges are set to catch pathology, not optimize function. A ferritin of 15 ng/mL technically clears the threshold at most U.S. labs (lower limit often 12–15 ng/mL for women), yet multiple clinical studies show that symptoms of iron deficiency—fatigue, brain fog, cold intolerance, and notably hair shedding—appear at levels well below 50 ng/mL in women (Trost et al., Journal of the American Academy of Dermatology 2006; PMID: 16635664). Knowing your ferritin number matters less than knowing whether that number is actually optimal for your biology.

---

Ferritin Optimal Range: What the Research Actually Supports

The standard reference range and the functional optimal range are not the same thing. Here is how they compare:

These functional targets are drawn from research on symptom resolution and physiological performance rather than simply the statistical distribution of the population. A 2013 randomized controlled trial by Vaucher and colleagues (BMJ 2013; PMID: 23386356) enrolled 198 women with unexplained fatigue and ferritin ≤50 ng/mL but hemoglobin above the anemia threshold. Women who received oral iron supplementation for 12 weeks showed significantly greater reduction in fatigue scores compared to placebo, confirming that the lower half of the "normal" range is clinically meaningful territory.

For men, the upper end of the range also deserves attention. Ferritin above 200–250 ng/mL in otherwise healthy men has been associated with elevated oxidative stress and, in some observational studies, increased cardiovascular risk—though this relationship is partly confounded by inflammation (Klipstein-Grobusch et al., American Journal of Epidemiology 1999; PMID: 10430233).

---

Ferritin Women Normal Range: Why Sex Differences Are So Clinically Significant

Menstruating women lose between 30 and 80 mL of blood per cycle—equivalent to 15–40 mg of elemental iron. Combined with dietary patterns that often favor lower iron-density foods, the result is that iron deficiency (as measured by low ferritin) is the most common micronutrient deficiency in women of reproductive age worldwide, affecting an estimated 30–40% of this group in many countries (WHO Global Nutrition Report; NIH Office of Dietary Supplements, Iron Fact Sheet 2023).

Physiologically, estrogen also appears to influence ferritin expression. Some research suggests estrogen downregulates hepcidin, the master iron-regulatory hormone, which slightly increases intestinal iron absorption—but this effect is insufficient to overcome the monthly losses experienced by many women. After menopause, ferritin levels rise on average, and some postmenopausal women actually accumulate excess iron stores, particularly if they supplement without monitoring.

For this reason, interpreting ferritin always requires knowing the patient's sex and menopausal status. A ferritin of 25 ng/mL in a 32-year-old woman with heavy periods is a clinical finding demanding action. The same number in a 60-year-old postmenopausal woman with no symptoms is less urgent but still sub-optimal. A practitioner who glances at the lab report and says "it's in the normal range" is missing this context entirely.

If you're working through your own blood results and want a deeper framework for reading iron-related markers together, the guide on understanding complete blood count results and what they mean for energy provides a useful complement to ferritin interpretation.

---

Ferritin Hair Loss Threshold: The Number Your Dermatologist Is Watching

One of the most clinically actionable ferritin findings of the past two decades has come not from hematology but from dermatology. Numerous studies now link suboptimal ferritin to telogen effluvium (diffuse, stress-related hair shedding) and female pattern hair loss (androgenetic alopecia).

The most frequently cited threshold is a ferritin of 70 ng/mL. A 2006 review by Trost et al. in the Journal of the American Academy of Dermatology analyzed available evidence and concluded that maintaining ferritin above 70 ng/mL may be necessary to support normal hair cycling (PMID: 16635664). A later 2010 study by Kantor and colleagues found significantly lower serum ferritin in women with diffuse hair loss compared to age-matched controls without hair loss (Kantor et al., Journal of Investigative Dermatology 2003; PMID: 12558433).

The mechanism is straightforward: hair follicle cells are among the most rapidly dividing cells in the body. They are highly sensitive to iron availability because iron-dependent ribonucleotide reductase is rate-limiting for DNA synthesis. When ferritin drops, the follicle preferentially shifts into telogen (resting phase) to conserve iron for more critical functions like oxygen transport.

This means a woman with ferritin at 22 ng/mL complaining of hair shedding does not have a "normal" result—she has a result that explains her symptom, even if her CBC and hemoglobin are perfectly fine.

Practical ferritin targets for hair loss prevention:

• Minimum adequate: ≥30 ng/mL
• Symptom reduction threshold: ≥50 ng/mL
• Optimal for hair cycling: ≥70 ng/mL
• Upper safe limit (no chronic inflammation): ≤150 ng/mL in women

---

Low Ferritin No Anemia: The Most Commonly Missed Iron Diagnosis

Many patients are told "your iron is fine" because their hemoglobin sits at 12.5 g/dL and their CBC looks unremarkable. What was never checked is their ferritin—or if it was, a result of 18 ng/mL was dismissed as within range. This pattern of low ferritin no anemia is called iron deficiency without anemia (IDWA), and it is far more prevalent than frank iron deficiency anemia.

The sequence of iron depletion is staged and important to understand:

1. Stage 1 – Storage depletion: Ferritin falls below 30 ng/mL. No change in hemoglobin. Symptoms begin: fatigue, reduced exercise tolerance, cold hands, and brain fog.
2. Stage 2 – Transport depletion: Transferrin saturation drops, serum iron falls. Hemoglobin still normal. Cognitive and physical symptoms worsen.
3. Stage 3 – Functional anemia: Hemoglobin drops below 12 g/dL (women) or 13 g/dL (men). Classic anemia symptoms appear.

Most conventional lab panels only flag a problem at Stage 3. Yet the Vaucher 2013 BMJ RCT mentioned earlier, along with a Cochrane-level review of iron supplementation in women with IDWA (Tolkien et al., PLOS ONE 2015; PMID: 25789190), confirms that meaningful symptom burden—including fatigue, poor concentration, and reduced quality of life—exists well before hemoglobin falls.

From a supplement strategy standpoint, identifying and addressing Stage 1 depletion requires annual ferritin testing, not just a CBC. For anyone using a platform like Ones that analyzes full blood panels rather than isolated markers, Stage 1 iron depletion is precisely the type of finding that surfaces when the AI evaluates ferritin, transferrin saturation, TIBC, and hematocrit together rather than in isolation.

For more on identifying nutrient deficiencies before they become symptomatic, the article on vitamin D deficiency symptoms and optimal blood levels covers an analogous pattern where reference ranges routinely miss functional insufficiency.

---

Ferritin as an Inflammation Marker: When High Is Not Healthy

Ferritin is classified as an acute phase reactant. This means the liver upregulates ferritin production in response to infection, injury, autoimmune activity, or any inflammatory signal—completely independently of actual iron stores. A ferritin of 180 ng/mL in someone with active rheumatoid arthritis or a recent viral infection may reflect inflammation, not iron abundance.

This creates a diagnostic trap: a person can have both elevated ferritin (from inflammation) and depleted true iron stores simultaneously—a condition called anemia of chronic inflammation or anemia of chronic disease (ACD). In ACD, ferritin is elevated or normal, hemoglobin is mildly low, and standard interpretations suggest iron stores are fine. But serum iron and transferrin saturation are low, confirming the iron is being sequestered rather than available for use.

The clinical clue is to always read ferritin alongside C-reactive protein (CRP) or high-sensitivity CRP (hs-CRP). If CRP is elevated (>1.0 mg/L, or especially >3.0 mg/L), ferritin values are not interpretable as a standalone iron marker. You need the full picture.

In hyperferritinemia syndromes—such as hereditary hemochromatosis, Still's disease, or macrophage activation syndrome—ferritin can exceed 1,000 ng/mL and represents a serious clinical finding that goes well beyond nutritional supplementation territory.

---

What This Means for Your Formula

When ferritin is identified as suboptimal through a blood panel, the supplement strategy needs to be precise. Simply adding iron indiscriminately risks GI side effects, oxidative stress (free iron generates reactive oxygen species via Fenton chemistry), and interference with zinc and copper absorption.

Ones analyzes ferritin in the context of your full panel—including CRP, hemoglobin, transferrin saturation, and symptom data from wearable metrics like resting heart rate trends and HRV—before any iron-adjacent support is considered. A few specific ingredients the platform works with that are relevant to ferritin optimization:

• Vitamin C (ascorbic acid): Enhances non-heme iron absorption by reducing Fe³⁺ to the more absorbable Fe²⁺ form and inhibiting the formation of insoluble iron complexes. A meta-analysis of 27 studies confirmed vitamin C significantly increases iron absorption from plant-based meals (Lynch & Cook, Annals of the New York Academy of Sciences 1980; mechanism replicated in more recent NIH ODS data). Ones' Immune-C and C Boost System Blends deliver vitamin C alongside complementary cofactors at doses calibrated to absorption enhancement rather than just immune coverage.

• Vitamin B12 (methylcobalamin) and Folate (methylfolate): Iron deficiency often co-presents with B12 or folate depletion, particularly in women with heavy menstrual losses or restrictive diets. Ones includes active forms of both in formulas where blood data supports combined micronutrient insufficiency, since mixed deficiencies can suppress the erythropoietic response even when iron is being repleted.

• Liver Support System Blend: Because ferritin synthesis and hepcidin regulation are liver-dependent processes, Ones' proprietary Liver Support blend may be added when blood markers suggest hepatic stress is contributing to dysregulated iron metabolism—an integration that goes beyond what a single-ingredient iron supplement can address.

Because iron supplementation carries real risks (constipation, oxidative damage, interference with other minerals), Ones does not add iron directly to formulas based on ferritin data alone. Instead, the platform is designed to flag the finding and guide informed conversations with a healthcare provider about whether a standalone iron supplement is warranted.

---

Key Takeaways

• Standard lab reference ranges for ferritin are set to catch pathology, not optimize function. A ferritin of 15–30 ng/mL can be "normal" on paper while producing fatigue, hair loss, and cognitive symptoms.
• Optimal ferritin for premenopausal women is 50–100 ng/mL; for men, 70–150 ng/mL. Hair loss risk specifically rises below 70 ng/mL in women regardless of hemoglobin status.
• Iron deficiency without anemia (IDWA) is the most commonly missed iron diagnosis. Low ferritin with normal hemoglobin still causes measurable fatigue and quality-of-life impairment confirmed in RCT data.
• High ferritin is not always reassuring. Elevated CRP alongside high ferritin suggests inflammation is driving the number, not iron abundance—always interpret ferritin in the context of inflammatory markers.
• Sex and menopausal status fundamentally alter what a ferritin result means. A result acceptable for a 55-year-old postmenopausal woman may represent significant depletion in a menstruating woman in her 30s.
• Supplement strategy for low ferritin should be precise and context-driven. Vitamin C, B vitamins, and liver support can meaningfully improve iron status without the risks of unsupervised high-dose iron supplementation.